Active Ingredient (In Each Tablet)
For 5 mg:
Cetirizine HCl USP 5 mg
For 10 mg:
Cetirizine HCl USP 10 mg
For 10 mg (Oval Shape):
Cetirizine HCl USP 10 mg
The following Structured Product Label (SPL) was submitted to the FDA by Marksans Pharma Limited for the product Cetirizine Hydrochloride Tablets, 5 Mg (NDC 25000-219). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, warnings, keep out of reach of children., directions, other information, inactive ingredients, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
For 5 mg:
Cetirizine HCl USP 5 mg
For 10 mg:
Cetirizine HCl USP 10 mg
For 10 mg (Oval Shape):
Cetirizine HCl USP 10 mg
Antihistamine
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
Do not use if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing hydroxyzine.
Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.
Ask a doctor or pharmacist before use if you are taking tranquilizers or sedatives.
When using this product
Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.
If pregnant or breast-feeding
In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
For 5 mg:
| adults and children 6 years and over | 1 tablet (5 mg) or 2 tablets (10 mg) once daily depending upon severity of symptoms; do not take more than 2 tablets (10 mg) in 24 hours |
| adults 65 years and over | 1 tablet (5 mg) once daily; do not take more than 1 tablet (5 mg) in 24 hours. |
| children under 6 years of age | ask a doctor |
| consumers with liver or kidney disease | ask a doctor |
For 10 mg:
| adults and children 6 years and over | one 10 mg tablet once daily; do not take more than one 10 mg tablet in 24 hours. A 5 mg product may be appropriate for less severe symptoms. |
| adults 65 years and over | ask a doctor |
| children under 6 years of age | ask a doctor |
| consumers with liver or kidney disease | ask a doctor |
•store between 20° to 25°C (68° to 77°F)
•do not use if foil seal under cap is broken or missing
corn starch, hypromellose, lactose monohydrate, magnesium stearate, polyethylene glycol, povidone, titanium dioxide
Questions or comments? Call 1-877-376-4271
(weekdays 9 AM to 5 PM)
NDC 25000-219-03
Cetirizine Hydrochloride Tablets USP, 5 mg
30s count bottle label
NDC 25000-219-03
Cetirizine Hydrochloride Tablets USP, 5 mg
30s count carton label
NDC 25000-219-08
Cetirizine Hydrochloride Tablets USP, 5 mg
100s count bottle label
NDC 25000-219-08
Cetirizine Hydrochloride Tablets USP, 5 mg
100s count carton label
NDC 25000-219-14
Cetirizine Hydrochloride Tablets USP, 5 mg
1000s count bottle label
NDC 25000-220-03
Cetirizine Hydrochloride Tablets USP, 10 mg
30s count bottle label
NDC 25000-220-03
Cetirizine Hydrochloride Tablets USP, 10 mg
30s count carton label
NDC 25000-220-08
Cetirizine Hydrochloride Tablets USP, 10 mg
100s count bottle label
NDC 25000-220-08
Cetirizine Hydrochloride Tablets USP, 10 mg
100s count carton label
NDC 25000-220-14
Cetirizine Hydrochloride Tablets USP, 10 mg
1000s count bottle label
NDC 25000-220-78
Cetirizine Hydrochloride Tablets USP, 10 mg
7s count carton label
NDC 25000-220-81
Cetirizine Hydrochloride Tablets USP, 10 mg
14s count carton label
NDC 25000-160-81
Cetirizine Hydrochloride Tablets USP, 10 mg (Oval Shape)
14s count carton label
NDC 25000-160-03
Cetirizine Hydrochloride Tablets USP, 10 mg (Oval Shape)
30s count carton label
NDC 25000-160-03 (Oval Shape)
Cetirizine Hydrochloride Tablets USP, 10 mg
30s count bottle label
NDC 25000-160-14
Cetirizine Hydrochloride Tablets USP, 10 mg (Oval Shape)
1000s count bottle label
* Please review the disclaimer below.